Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vi (Q43204188)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vi |
scientific article published in February 2010 |
Statements
Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models (English)
Christopher J O'Donnell
Bruce N Rogers
Brian S Bronk
Dianne K Bryce
Jotham W Coe
Karen K Cook
Edelweiss Evrard
Mihaly Hajós
William E Hoffmann
Raymond S Hurst
Noha Maklad
Robert J Mather
Stafford McLean
Frank M Nedza
Brian T O'Neill
Langu Peng
Weimin Qian
Melinda M Rottas
Steven B Sands
Anne W Schmidt
Alka V Shrikhande
Douglas K Spracklin
Diane F Wong
Andy Zhang